Cargando…
Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin
BACKGROUND: Human serum albumin (HSA)—one of the most demanded therapeutic proteins with immense biotechnological applications—is a large multidomain protein containing 17 disulfide bonds. The current source of HSA is human blood plasma which is a limited and unsafe source. Thus, there exists an ind...
Autores principales: | Sharma, Ashima, Chaudhuri, Tapan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629808/ https://www.ncbi.nlm.nih.gov/pubmed/28982367 http://dx.doi.org/10.1186/s12934-017-0784-8 |
Ejemplares similares
-
Enhanced production of recombinant serratiopeptidase in Escherichia coli and its characterization as a potential biosimilar to native biotherapeutic counterpart
por: Srivastava, Vishal, et al.
Publicado: (2019) -
Microbial factories: monitoring vitamin B(2) production by Escherichia coli in microfluidic cultivation chambers
por: Jusková, Petra, et al.
Publicado: (2021) -
Escherichia coli redox mutants as microbial cell factories for the synthesis of reduced biochemicals
por: Ruiz, Jimena A., et al.
Publicado: (2013) -
Artificial cell factory design for shikimate production in Escherichia coli
por: Lee, Han-Na, et al.
Publicado: (2021) -
Engineered Escherichia coli cell factory for anthranilate over-production
por: Kim, Hye-Jin, et al.
Publicado: (2023)